- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech High Insider Buying
Swedish Pharmaceuticals & Biotech High Insider Buying
Results
13
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
13 companies
BioGaia
Market Cap: SEK 10.2b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 100.90
7D
-0.4%
1Y
-5.7%
Swedencare
Market Cap: SEK 6.0b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 37.65
7D
3.9%
1Y
-23.0%
Egetis Therapeutics
Market Cap: SEK 2.1b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
EGTX
SEK 5.19
7D
-0.4%
1Y
-7.5%
Devyser Diagnostics
Market Cap: SEK 1.9b
Engages in the development, manufacture, and sale of diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.
DVYSR
SEK 113.40
7D
4.0%
1Y
-12.8%
Enzymatica
Market Cap: SEK 468.5m
A life science company, develops and sells medical devices for infection-related diseases.
ENZY
SEK 1.93
7D
1.8%
1Y
8.4%
Ascelia Pharma
Market Cap: SEK 340.5m
A biotech company, develops identifies, develops, and commercializes novel drugs to treat orphan oncology treatments in Sweden.
ACE
SEK 2.69
7D
-0.9%
1Y
-7.4%
Promimic
Market Cap: SEK 298.5m
Manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets.
PRO
SEK 15.80
7D
-7.3%
1Y
-41.3%
Mendus
Market Cap: SEK 258.7m
A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.
IMMU
SEK 5.10
7D
-5.6%
1Y
-39.9%
IRLAB Therapeutics
Market Cap: SEK 180.9m
IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.
IRLAB A
SEK 2.13
7D
6.5%
1Y
-83.0%
Biovica International
Market Cap: SEK 145.9m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.
BIOVIC B
SEK 0.53
7D
-6.7%
1Y
-79.0%
OncoZenge
Market Cap: SEK 70.6m
A pharmaceutical company, engages in the development of treatment for pain relief in patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer in Sweden.
ONCOZ
SEK 5.58
7D
0.2%
1Y
31.1%
Prostatype Genomics
Market Cap: SEK 35.5m
Prostatype Genomics AB manufactures, markets, and sells prognostic gene tests.
PROGEN
SEK 0.60
7D
6.8%
1Y
-92.0%
PharmaLundensis
Market Cap: SEK 15.3m
PharmaLundensis AB operates as a pharmaceutical company.
PHAL
SEK 0.36
7D
0%
1Y
-44.6%